EA200501221A1 - Фармацевтическая композиция алендроновой кислоты, ее солей или сложных эфиров и способ ее получения - Google Patents
Фармацевтическая композиция алендроновой кислоты, ее солей или сложных эфиров и способ ее полученияInfo
- Publication number
- EA200501221A1 EA200501221A1 EA200501221A EA200501221A EA200501221A1 EA 200501221 A1 EA200501221 A1 EA 200501221A1 EA 200501221 A EA200501221 A EA 200501221A EA 200501221 A EA200501221 A EA 200501221A EA 200501221 A1 EA200501221 A1 EA 200501221A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- salts
- preparation
- pharmaceutical composition
- airs
- complex
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
В изобретении описаны пероральная фармацевтическая композиция с алендроновой кислотой, ее солями или сложными эфирами и способ ее получения.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200300052A SI21403A (sl) | 2003-02-27 | 2003-02-27 | Farmacevtska oblika z alendronsko kislino, njenimi solmi ali estri ter postopek za njeno pripravo |
PCT/SI2004/000011 WO2004075828A2 (en) | 2003-02-27 | 2004-02-26 | Pharmaceutical composition of alendronic acid, salts or esters thereof, and a process for its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200501221A1 true EA200501221A1 (ru) | 2006-04-28 |
EA009333B1 EA009333B1 (ru) | 2007-12-28 |
Family
ID=32906916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200501221A EA009333B1 (ru) | 2003-02-27 | 2004-02-26 | Фармацевтическая композиция алендроновой кислоты, ее солей или сложных эфиров и способ ее получения |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1599191B1 (ru) |
AT (1) | ATE464884T1 (ru) |
CA (1) | CA2517372C (ru) |
DE (1) | DE602004026689D1 (ru) |
EA (1) | EA009333B1 (ru) |
PL (1) | PL377706A1 (ru) |
SI (1) | SI21403A (ru) |
WO (1) | WO2004075828A2 (ru) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1781258A1 (en) * | 2004-08-20 | 2007-05-09 | Mepha AG | Formulations of bisphosphonates |
WO2006054165A1 (en) * | 2004-11-19 | 2006-05-26 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of alendronic acid and processes for their preparation |
PE20070698A1 (es) * | 2005-11-14 | 2007-08-17 | Teijin Pharma Ltd | Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol |
US20080131467A1 (en) * | 2006-11-30 | 2008-06-05 | Dennis Nelson | Film-coated solid dosage form |
WO2009018834A1 (en) * | 2007-08-06 | 2009-02-12 | Pharmathen S.A. | Pharmaceutical composition containing bisphosphonate and method for the preparation thereof |
CN103384517A (zh) * | 2010-12-22 | 2013-11-06 | 巴斯夫欧洲公司 | 快速崩解的固体包衣剂型 |
US8715729B2 (en) | 2010-12-22 | 2014-05-06 | Basf Se | Rapidly disintegrating, solid coated dosage form |
CN116211818B (zh) * | 2023-03-10 | 2024-04-09 | 菲洋生物科技(吉林)有限公司 | 一种含有阿仑膦酸钠的片剂及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL121623A (en) * | 1997-08-26 | 2000-06-29 | Unipharm Ltd | Process for the preparation of solid oral dosage forms comprising alendronic acid |
US6432448B1 (en) * | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
AU1195001A (en) * | 1999-10-11 | 2001-04-23 | Monsanto Company | Tablets coated with locust bean gum, guar gum or carrageenan gum |
US6476006B2 (en) * | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
-
2003
- 2003-02-27 SI SI200300052A patent/SI21403A/sl not_active IP Right Cessation
-
2004
- 2004-02-26 CA CA2517372A patent/CA2517372C/en not_active Expired - Fee Related
- 2004-02-26 PL PL377706A patent/PL377706A1/pl not_active Application Discontinuation
- 2004-02-26 DE DE602004026689T patent/DE602004026689D1/de not_active Expired - Lifetime
- 2004-02-26 AT AT04714997T patent/ATE464884T1/de not_active IP Right Cessation
- 2004-02-26 EP EP04714997A patent/EP1599191B1/en not_active Expired - Lifetime
- 2004-02-26 EA EA200501221A patent/EA009333B1/ru not_active IP Right Cessation
- 2004-02-26 WO PCT/SI2004/000011 patent/WO2004075828A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2004075828A3 (en) | 2004-10-28 |
EA009333B1 (ru) | 2007-12-28 |
CA2517372C (en) | 2012-07-17 |
EP1599191B1 (en) | 2010-04-21 |
WO2004075828A2 (en) | 2004-09-10 |
CA2517372A1 (en) | 2004-09-10 |
EP1599191A2 (en) | 2005-11-30 |
PL377706A1 (pl) | 2006-02-06 |
ATE464884T1 (de) | 2010-05-15 |
DE602004026689D1 (de) | 2010-06-02 |
SI21403A (sl) | 2004-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1110318T1 (el) | Παραγωγα φαινοξυοξικου οξεος | |
BRPI0415288A (pt) | composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto | |
CY1107841T1 (el) | Φαρμακευτικα σκευασματα τα οποια περιλαμβανουν μυκοφαινολικο οξυ ή μυκοφαινολικο αλας | |
DE60200412D1 (de) | Polyhydroxyalkanoat und Verfahren zu dessen Herstellung, und Omega-(2-Thienylsulfanyl)alkansäure und Verfahren zu deren Herstellung | |
ATE457719T2 (de) | Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel | |
WO2010078486A3 (en) | Opioid-containing oral pharmaceutical compositions and methods | |
WO2008022932A3 (en) | Controlled release system and method for manufacturing the same | |
DE602005000765D1 (de) | Verfahren zur Herstellung von Ivabradine und deren pharmazeutisch verträgliche Säureadditionssalze | |
WO2007078874A3 (en) | Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors | |
CY1113231T1 (el) | Απαραβιαστες φαρμακοτεχνικες μορφες δοσολογιας απο του στοματος περιλαμβανουσες ενα οπιουχο αναλγητικο | |
DE60210552D1 (de) | Prozess zur Herstellung einer festen pharmazeutischen Zubereitung welche einen schwerlöslichen Wirkstoff enthält | |
EA200702589A1 (ru) | 2,6-хинолинильные производные, способы их получения и их применение | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
CY1124650T1 (el) | Φαρμακευτικο παρασκευασμα που περιεχει ινσουλινη σε κρυσταλλικη μορφη καθως και σε διαλυτοποιημενη μορφη | |
ATE429903T1 (de) | Pharmazeutische zubereitung mit verzögerter wirkstoff-freisetzung enthaltend milchsäure- glycolsäure copolymer, und verfahren zu deren herstellung | |
BRPI0817275A2 (pt) | Combinação farmacêutica de alisquireno e valsartana | |
SG156633A1 (en) | Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same | |
EA200501221A1 (ru) | Фармацевтическая композиция алендроновой кислоты, ее солей или сложных эфиров и способ ее получения | |
DE60120109D1 (de) | Verfahren zur herstellung von optisch-reinen (r)- und (s)- didesmethylsibutramin | |
WO2005046727A3 (en) | Ibuprofen-containing soft gelatin capsules | |
DE602004014805D1 (de) | Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten | |
WO2005063219A3 (en) | Ibuprofen-containing soft gelatin capsules | |
WO2009100107A3 (en) | Alendronate formulations, method of making and method of use thereof | |
BR0208593A (pt) | método para o tratamento de um mamìfero, composto, e, composição farmacêutica | |
ATE439125T1 (de) | Fenofibrate tablett und verfahren zur herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): KZ RU |